Fundraising FoxAventera Antibodies
Lund, SE · 1 known investors
Find your way into Aventera Antibodies
232 people in our graph share verified history with the Aventera Antibodies team — schools, employers, funds. One of them is your warm intro.
Emilia Carlqvistunlockedknows Arman Izadi · together at Region Skåne (overlapped)
×4knows the team · via Cytely AB
knows the team · via Scripps Research
×6knows the team · via Lund University
Aventera Antibodies is a preclinical biotech developing a first-in-class precision immunotherapy — an engineered monoclonal antibody — against invasive Group A Streptococcal (iGAS) infections, with first-in-human trials planned for 2028. The therapy is intended to be paired with rapid Strep-A diagnostics to enable early clinical intervention.
Founders & leadership
AI
Arman IzadiCEO & FounderArman Izadi is a physician-scientist with clinical training from Karolinska University Hospital and research experience in Fc-engineered antibodies at Lund University. He is CEO and founder of Aventera Antibodies, a biotech company developing engineered monoclonal antibodies to treat invasive Group A Streptococcal infections.
PN
Pontus NordenfeltChairman of the Scientific Advisory Board, Board of Directors, FounderPontus Nordenfelt holds a PhD in Cell Biology from Lund University and an MSc in Chemical Engineering/Biotechnology from Lund Institute of Technology; he was an Associate Professor in Infection Medicine at Lund University with postdoctoral training at Harvard Medical School under Timothy Springer and at Sick Kids Toronto, and previously led a research group studying host-pathogen interactions and antibody biology.
Investors · 1
Frequently asked questions
- What does Aventera Antibodies do?
- Aventera Antibodies is a preclinical biotech developing a first-in-class precision immunotherapy — an engineered monoclonal antibody — against invasive Group A Streptococcal (iGAS) infections, with first-in-human trials planned for 2028. The therapy is intended to be paired with rapid Strep-A diagnostics to enable early clinical intervention.
- Who founded Aventera Antibodies?
- Aventera Antibodies was founded by Arman Izadi, Pontus Nordenfelt.
- Who are Aventera Antibodies's investors?
- Aventera Antibodies's investors include LU Innovation.
- Where is Aventera Antibodies headquartered?
- Aventera Antibodies is headquartered in Lund, SE.